France· FR:64102427
PERGOVERIS (450 UI + 225 UI)/0,72 mL, solution injectable en stylo prérempli
A medicinal product containing follitropine alfa + lutropine alfa, registered in France by MERCK EUROPE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FOLLITROPINE ALFA + LUTROPINE ALFA
- Manufacturer
- MERCK EUROPE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300892241 stylo prérempli en verre de 0,72 mL + 7 aiguillesEUR 193.43
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropine alfa + lutropine alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPERGOVERIS (300 UI + 150 UI)/0,48 ML SOLUCION INYECTABLE EN PLUMA PRECARGADAMerck Europe B.V.
- CzechiaPERGOVERISMerck Europe B.V., Amsterdam
- FinlandPergoverisOrifarm Oy
- IrelandPergoveris (300 IU + 150 IU)/0.48 mL solution for injection in pre-filled penMerck Europe B.V.
- United KingdomPergoveris 150unit/75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandPergoverisMerck Europe B.V.*
- PolandPergoverisMerck Europe B.V.
- CanadaPERGOVERISEMD SERONO, A DIVISION OF EMD INC., CANADA
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pergoveris
- Liechtenstein · Pergoveris
- Norway · Pergoveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7bad236-15b0-4b3d-9b15-710d375d3ac0 GET /v1/drugs/d7bad236-15b0-4b3d-9b15-710d375d3ac0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64102427",
"date_amm": "2017-05-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/396",
"substance": "FOLLITROPINE ALFA + LUTROPINE ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about follitropine alfa + lutropine alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.